Literature DB >> 4190466

[Pathogenesis of drug allergic reactions on the skin].

G Lüders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4190466

Source DB:  PubMed          Journal:  Arch Klin Exp Dermatol        ISSN: 0300-8614


× No keyword cloud information.
  36 in total

1.  ARTERIOLITIS (VASCULITIS) "ALLERGICA" CUTIS (SUPERFICIALIS). A NEW DERMATOLOGICAL CONCEPT.

Authors:  M RUITER
Journal:  Dermatologica       Date:  1964

2.  [Side-effects of drugs].

Authors:  W ADAM
Journal:  Dermatol Wochenschr       Date:  1961-09-23

3.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

4.  [Desmosomes].

Authors:  G PETRY
Journal:  Dtsch Med Wochenschr       Date:  1962-05-11       Impact factor: 0.628

5.  [On various presumably allergic vascular diseases].

Authors:  H Storck; H Eichenberger-de Beer
Journal:  Med Klin       Date:  1967-07-28

6.  [On the etiopathogenesis of vasculitis].

Authors:  H Kresbach
Journal:  Arch Klin Exp Dermatol       Date:  1966

7.  [Immunfluorescence investigations in various dermatoses. IV. Proof of antigen at positive potassium bichromate pathc skin test with the direct immunofluorescence method].

Authors:  H Heise; A Mattheus
Journal:  Arch Klin Exp Dermatol       Date:  1968

8.  [Immunofluorescence studies in various dermatoses. I. Production of fluorochromium labelled antisera].

Authors:  H Heise; A Mattheus
Journal:  Arch Klin Exp Dermatol       Date:  1966

9.  Nodular vasculitis: immunofluorescent study; 7S gamma-globulin and complement (beta-1c-globulin) in lesions of nodular vasculitis.

Authors:  S G Stringa; C Bianchi; S B Zingale
Journal:  J Invest Dermatol       Date:  1966-01       Impact factor: 8.551

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.